YESONG Co., Ltd. was established in 2014, based on the values of a reliable company.
From the first year of foundation, through continuous research and development, we developed ‘YES PATH LBC System’, a ‘Liquid Based Cytology System’ for cancer diagnosis in 2019.

‘YES PATH LBC System’ started development by prioritizing patients’ lives and the medical staffs‘ position. And it is a Liquid Based Cytology inspection system that incorporates a unique new technology called ‘Inverse dispersion pumping’.

The ‘LBC System’, which has been developed, launched, and commercialized since the mid-1990’s by a global company, demands continuous improvement have been raised along with various developments in the medical field.

By converging the voices of the medical field as much as possible, the ‘YES PATH LBC System’ is an LBC system that is expressed and reflected with our own technology.

We are constantly devoting ourselves to developing the most optimal and adequate LBC system for cytology diagnosis, which is a basic medical field for cancer diagnosis, and ultimately aiming for human health and happiness.
We are YESONG.

Thank you.

CEO. Ye Chen Su
Company Name YESONG Co., Ltd.
CEO YE CHEN SU
Business Area Export and manufacture of In Vitro Diagnostic Medical Devices and Reagents In Vitro Diagnostic Medical Device R & D
General Office / Factory&Lab #808, Byeoksan Digital Valley 2-cha, 184, Gasan digital 2-ro, Geumcheon-gu, Seoul, Republic of Korea
Established date 2014. 12. 04